{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:59:21Z","timestamp":1775077161568,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T00:00:00Z","timestamp":1365984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2261-13-28","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T14:43:02Z","timestamp":1366036982000},"source":"Crossref","is-referenced-by-count":42,"title":["Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial"],"prefix":"10.1186","volume":"13","author":[{"given":"Marcello","family":"Disertori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Franzosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Barlera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Cosmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Quintarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Favero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glauco","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo Pietro","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Staszewsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Andrea","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Latini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,15]]},"reference":[{"key":"566_CR1","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","volume":"114","author":"V Fuster","year":"2006","unstructured":"Fuster V, Ryd\u00e9n LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V: ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines: developed in collaboration with the European Heart Rhythm association and the Heart Rhythm Society. Circulation. 2006, 114: e257-e354.","journal-title":"Circulation"},{"key":"566_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI: Metanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007, 146: 857-867. 10.7326\/0003-4819-146-12-200706190-00007.","journal-title":"Ann Intern Med"},{"key":"566_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","volume":"151","author":"DE Singer","year":"2009","unstructured":"Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS: The net clinical benefit of warfarin in anticoagulation in atrial fibrillation. Ann Intern Med. 2009, 151: 297-305. 10.7326\/0003-4819-151-5-200909010-00003.","journal-title":"Ann Intern Med"},{"key":"566_CR4","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillation. JAMA. 2001, 285: 2864-2870. 10.1001\/jama.285.22.2864.","journal-title":"JAMA"},{"key":"566_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jacc.2007.09.065","volume":"51","author":"MC Fang","year":"2008","unstructured":"Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki , Singer DE: Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2008, 51: 810-815. 10.1016\/j.jacc.2007.09.065.","journal-title":"J Am Coll Cardiol"},{"key":"566_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest. 2010, 137: 263-272. 10.1378\/chest.09-1584.","journal-title":"Chest"},{"key":"566_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","volume":"35","author":"RG Hart","year":"2000","unstructured":"Hart RG, Pearce LA, Rothbart RM, McAnulty JN, Asinger RW, Halperin JL: Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. J Am Coll Cardiol. 2000, 35: 183-187. 10.1016\/S0735-1097(99)00489-1.","journal-title":"J Am Coll Cardiol"},{"key":"566_CR8","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.jacc.2007.07.076","volume":"50","author":"SH Hohnloser","year":"2007","unstructured":"Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ: Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy. An ACTIVE W Substudy. J Am Coll Cardiol. 2007, 50: 2156-2161. 10.1016\/j.jacc.2007.07.076.","journal-title":"J Am Coll Cardiol"},{"key":"566_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2796.2007.01909.x","volume":"264","author":"GYH Lip","year":"2008","unstructured":"Lip GYH, Frison L, Grind M: Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation. J Intern Med. 2008, 264: 50-61. 10.1111\/j.1365-2796.2007.01909.x.","journal-title":"J Intern Med"},{"key":"566_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","volume":"31","author":"L Friberg","year":"2010","unstructured":"Friberg L, Hammar N, Rosenqvist M: Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J. 2010, 31: 967-975. 10.1093\/eurheartj\/ehn599.","journal-title":"Eur Heart J"},{"key":"566_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/eurheartj\/ehn139","volume":"29","author":"R Nieuwlaat","year":"2008","unstructured":"Nieuwlaat R, Prins MH, Le Heuzey J-Y, Vardas PE, Aliot E, Santini M, Cobbe SM, Widdershoven J, Baur LH, Levy S, Crijns HJ: Prognosis, disease progression, and treatment of atrial fibrillation patients during 1\u00a0year: follow-up of the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2008, 29: 1181-1189. 10.1093\/eurheartj\/ehn139.","journal-title":"Eur Heart J"},{"key":"566_CR12","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1056\/NEJMoa0805710","volume":"360","author":"The GISSI-AF Investigators","year":"2009","unstructured":"The GISSI-AF Investigators: Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med. 2009, 360: 1606-1617.","journal-title":"N Engl J Med"},{"key":"566_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","volume":"105","author":"RJ Beyth","year":"1998","unstructured":"Beyth RJ, Quinn LM, Landefeld CS: Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998, 105: 91-99. 10.1016\/S0002-9343(98)00198-3.","journal-title":"Am J Med"},{"key":"566_CR14","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1161\/CIR.0b013e318214876d","volume":"123","author":"V Fuster","year":"2011","unstructured":"Fuster V, Ryd\u00e9n LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Heuzey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Priori SG, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Jacobs AK, Anderson JL, Albert N, Buller CE, Creager MA: 2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2011, 123: e269-e367. 10.1161\/CIR.0b013e318214876d.","journal-title":"Circulation"},{"key":"566_CR15","doi-asserted-by":"publisher","first-page":"546S","DOI":"10.1378\/chest.08-0678","volume":"133","author":"DE Singer","year":"2008","unstructured":"Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ: Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidenced-based clinical practice guidelines (8th Edition). Chest. 2008, 133: 546S-592S. 10.1378\/chest.08-0678.","journal-title":"Chest"},{"key":"566_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ahj.2011.05.008","volume":"162","author":"M Disertori","year":"2011","unstructured":"Disertori M, Lombardi F, Barlera S, Maggioni AP, Favero C, Franzosi MG, Lucci D, Staszewsky L, Fabbri G, Quintarelli S, Bianconi R, Latini R: Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Am Heart J. 2011, 162: 382-389. 10.1016\/j.ahj.2011.05.008.","journal-title":"Am Heart J"},{"key":"566_CR17","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1161\/01.STR.0000181115.59173.42","volume":"36","author":"H Arima","year":"2005","unstructured":"Arima H, Hart RG, Colman S, Chalmers S, Anderson C, Rodgers A, Woodward M, MacMahon S, Neal B: Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke. 2005, 36: 2164-2169. 10.1161\/01.STR.0000181115.59173.42.","journal-title":"Stroke"},{"key":"566_CR18","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.105.553438","volume":"112","author":"MC Fang","year":"2005","unstructured":"Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Go AS: Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation : The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2005, 112: 1687-1691. 10.1161\/CIRCULATIONAHA.105.553438.","journal-title":"Circulation"},{"key":"566_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijcard.2011.04.022","volume":"161","author":"TS Potpara","year":"2011","unstructured":"Potpara TS, Marinkovic JM, Polovina MM, Stankovic GR, Seferovic PM, Ostojic MC, Lip GY: Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: The Belgrade atrial fibrillation study. Int J Cardiol. 2011, 161: 39-44.","journal-title":"Int J Cardiol"},{"key":"566_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.amjcard.2009.11.047","volume":"105","author":"PR Kowey","year":"2010","unstructured":"Kowey PR, Reiffel JA, Myerburg R, Naccarelli GV, Parker DL, Pratt CM, Reiter M, Waldo AL: Warfarin and Aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). Am J Cardiol. 2010, 105: 1130-1134. 10.1016\/j.amjcard.2009.11.047.","journal-title":"Am J Cardiol"},{"key":"566_CR21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/clc.20967","volume":"34","author":"SH Chae","year":"2011","unstructured":"Chae SH, Froehlich J, Morady F, Oral H: Prevalence and predictors of warfarin use in patients with atrial fibrillation at low or intermediate risk and relation to thromboembolic events. Clin Cardiol. 2011, 34: 640-644. 10.1002\/clc.20967.","journal-title":"Clin Cardiol"},{"key":"566_CR22","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1093\/eurheartj\/ehl146","volume":"27","author":"L Friberg","year":"2006","unstructured":"Friberg L, Hammar N, Ringh M, Petterson H, Rosenqvist M: Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J. 2006, 27: 1954-1964. 10.1093\/eurheartj\/ehl146.","journal-title":"Eur Heart J"},{"key":"566_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","volume":"20","author":"GL Botto","year":"2009","unstructured":"Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G: Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol. 2009, 20: 241-248. 10.1111\/j.1540-8167.2008.01320.x.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"566_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","volume":"2","author":"TV Glotzer","year":"2009","unstructured":"Glotzer TV, Daud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD: The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk. The TRENDS Study. Circ Arrhythm Electrophysiol. 2009, 2: 474-480. 10.1161\/CIRCEP.109.849638.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"566_CR25","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/STROKEAHA.110.609297","volume":"42","author":"G Boriani","year":"2011","unstructured":"Boriani G, Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Ricci R, Biffi M, De Santo T, Corbucci G, Lip GY: Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk score in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke. 2011, 42: 1768-1770. 10.1161\/STROKEAHA.110.609297.","journal-title":"Stroke"},{"key":"566_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH: Subclinical atrial fibrillation and risk of stroke. N Engl J Med. 2012, 366: 120-129. 10.1056\/NEJMoa1105575.","journal-title":"N Engl J Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-13-28\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-13-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-13-28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-13-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:34:42Z","timestamp":1548189282000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-13-28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-13-28","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,15]]},"article-number":"28"}}